MannKind Corporation is engaged in the discovery, development and commercialization of therapeutic products for patients with diseases like diabetes and cancer. AFREZZA, the company’s lead product candidate, is currently in late-stage clinical investigation for the treatment of adults with type 1 or 2 diabetes for the control of hyperglycemia. For more information, visit the company’s Web site at www.mannkindcorp.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: